This conference report of the 8th International RASopathies symposium highlights global perspectives on clinical care and research.
To ensure that a patient’s test is billed to their 2024 health benefits, testing must be started before the end of the year. For exome, genome, or Xpanded testing, if you do not expect parental samples to be received before the end of the year, please contact us at support@genedx.com to determine how to proceed.
This conference report of the 8th International RASopathies symposium highlights global perspectives on clinical care and research.